Enoxaparin-induced psoas hematoma complicated by Staphylococcus aureus infection after cardiac catheterization

Thrombosis Research

Volumn 118, Issue 4, 2006, Pages 535-537

  Ziakas, A ^a   Konstantinou, V ^a   Giannoglou, G ^a   Gemitzis, K ^a   Louridas, G ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERACILLIN PLUS TAZOBACTAM; TROPONIN T; VANCOMYCIN;

ADULT; ANGIOCARDIOGRAPHY; BLOOD CULTURE; BLOOD EXAMINATION; CASE REPORT; CHILL; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; CORONARY ARTERY OBSTRUCTION; COUGHING; DYSPNEA; FEVER; HEART CATHETERIZATION; HEART INFARCTION; HEMOPTYSIS; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ILIOPSOAS HEMATOMA; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LETTER; LOW BACK PAIN; MALE; PARACENTESIS; PRIORITY JOURNAL; PSOAS MUSCLE; RIGHT CORONARY ARTERY; RISK FACTOR; SEPTICEMIA; ST SEGMENT DEPRESSION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SWEATING; SWELLING; THORAX PAIN; THORAX RADIOGRAPHY;

ENOXAPARIN; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEMATOMA; HUMANS; MALE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33747871486     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.09.009     Document Type: Letter

References (22)

1. Gwost J., Stoebe T., Chesler E., and Weir K.E. Analysis of the complications of cardiac catheterization over nine years. Catheter Cardiovasc Diagn 8 (1982) 13-21
2. Dorros G., Cowley M.J., Simpson J., Bentivoglio L.G., Block P.C., Bourassa M., et al. Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA registry. Circulation 67 (1983) 723-730
3. Samson R.H., Sprayregen S., Veith F.J., Scher L.A., Gupta S.K., and Ascer E. Management of angioplasty complications, unsuccessful procedures and early and late failures. Ann Surg 199 (1984) 234-240
4. McReady R.A., Siderys H., Pittman J.N., Herod G.T., Halbrook H.G., Fehrenbacher J.W., et al. Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. J Vasc Surg 14 2 (1991) 170-174
5. Samore M.H., Wessolossky M.A., Lewis S.M., Shubrooks S.J., and Karchmer A.W. Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol 79 (1997) 873-877
6. Shea K.W., Schwartz R.K., Gambino A.T., Marzo K.P., and Cunha B.A. Bacteremia associated with percutaneous transuminal coronary angioplasty. Catheter Cardiovasc Diagn 36 (1995) 5-9
7. Frazee B.W., and Flaherry J.P. Septic endarteritis of the femoral artery following angioplasty. Rev Infect Dis 13 (1991) 620-623
8. Klein S.M., D'Ercole F., Greengrass R.A., and Warner D.S. Enoxaparin associated with psoas hematoma and lumbar plexopathy after lumpar plexus block. Anesthesiology 87 (1997) 1576-1579
9. Ho K.J., Gawley S.D., and Young M.R. Psoas hematoma and femoral neuropathy associated with enoxaparin therapy. Int J Clin Pract 57 6 (2003 (Jul-Aug)) 553-554
10. Cohen M., Demers C., Gurfinkel E.P., Turpie A.G., Fromell G.J., Goodman S., et al. A comparison of low molecular weight heparin with unfractioned heparin for unstable coronary artery disease. N Engl J Med 337 (1997) 447-452
11. Antman E.M., and TIMI IIb investigators. TIMI IIb. Enoxoparin versus unfractioned heparin for unstable angina or non Q wave myocardial infarction. A double-blind, placebo-controlled parallel group multicenter trial. Am heart J 135 (1998) 5353-5360
12. Antonelli D., Fares L., and Anene Ch. Enoxaparin associated with huge abdominal wall hematomas: a report of two cases. Am Surg 66 (2000) 797-800
13. Houde J.P., and Steinberg G. Intrahepatic hemorrhage after use of low-molecular-weight heparin for total hip arthoplasty. J Arthroplasty 14 (1999) 372-374
14. Kumar P.D. Thigh hematoma after femoral venipuncture in a patient treated with low-molecular-weight heparin. Arch Intern Med 161 (2001) 1113-1114
15. Montoya J.P., Pokala N., and Melde S.L. Retroperitoneal hematoma and enoxaparin. Ann Intern Med 131 (1999) 796-797
16. Dabney A., and Bastani B. Enoxaparin-associated severe retroperitoneal bleeding and abdominal compartment syndrome: a report of two cases. Intensive Care Med 27 (2001) 1954-1957
17. Chan-Tack K.M. Fatal spontaneous retroperitoneal hematoma secondary to enoxaparin. South Med J 96 (2003) 58-60
18. Wysowski D.K., Talarico L., Bascanyi J., and Botstein P. Spinal and apidural hematoma and low-molecular-weight heparin. N Engl J Med 338 (1998) 1774-1775
19. Melde S.L. Enoxaparin induced retroperitoneal hematoma. Ann Pharmacother 37 6 (2003) 822-824
20. Sasson Z., Mangat I., and Peckman K.A. Spontaneous iliopsoas hematoma in patients with unstable coronary syndromes receiving intravenous heparin in therapeutic doses. Can J Cardiol 12 5 (1996) 490-494
21. Kardaras F.G., Kardara D.F., Rontogiani D.P., Mpourazanis I.A., and Flessas L.P. Septic endarteritis following percutaneous transluminal coronary angioplasty. Catheter Cardiovasc Diagn 34 (1995) 57-60
22. Clevelant K.O., and Gelfand M.S. Invasive staphylococcal infections complicating percutaneous transluminal coronary angiollasty: three cases and review. Clin Infect Dis 21 (1995) 93-96